M&A Deal Summary

Ampersand Capital Partners Acquires Phosphorex

On August 25, 2022, growth capital firm Ampersand Capital Partners acquired transportation company Phosphorex

Acquisition Highlights
  • This is Ampersand Capital Partners’ 1st transaction in the Transportation sector.
  • This is Ampersand Capital Partners’ 62nd transaction in the United States.
  • This is Ampersand Capital Partners’ 15th transaction in Massachusetts.

M&A Deal Summary
Date 2022-08-25
Target Phosphorex
Sector Transportation
Buyer(s) Ampersand Capital Partners
Deal Type Recapitalization

Target

Phosphorex

Hopkinton, Massachusetts, United States
Phosphorex is specializes in long-acting formulations, nanomedicine, and nucleic acid delivery solutions for leading pharmaceutical and biotechnology companies. Phosphorex was founded in 2005 and is based in Hopkinton, Massachusetts.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Ampersand Capital Partners

Wellesley, Massachusetts, United States

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1988
PE ASSETS 3.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.

DEAL STATS #
Overall 73 of 84
Sector (Transportation) 1 of 1
Type (Recapitalization) 5 of 7
State (Massachusetts) 15 of 15
Country (United States) 62 of 69
Year (2022) 8 of 11
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-23 Vantage MedTech

Moonachie, New Jersey, United States

Vantage MedTech is a provider of custom electromechanical and software solutions for the medical device industry. Vantage MedTech was founded in 1998 and is based in Moonachie, New Jersey.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-09-01 Flagship Biosciences

Broomfield, Colorado, United States

Flagship Biosciences is a technology-driven tissue analysis services company delivering accurate and informative data available. Flagship Biosciences' services and technology dramatically improve the data and interpretation from traditional pathology methods, eliminating variability associated with typical tissue assessments, and bringing new insights to tissue analysis results. It provides expert scientific consultation for every client. The company's team interprets results, contextualizes tissue biology, and identifies the best course for success. Flagship Biosciences was formed in 2009 and is based in Broomfield, Colorado.

Buy -
Mergr

Product

Company

Legal